Perthera
1616 Anderson Road
McLean
Virginia
22102
United States
Tel: 877-827-7893
Fax: 888-965-8043
Website: https://www.perthera.com/
15 articles about Perthera
-
New Research Reveals Pancreatic Cancer Patients Who Receive Precision Medicine Live An Average Of One Year Longer Than Those Who Do Not
3/3/2020
Pancreatic Cancer Action Network and Perthera Study in Lancet Oncology Underscores the Urgent Need for Every Pancreatic Cancer Patient to Get Tested Through a Molecular Profiling Platform
-
Perthera Builds Its Senior Management Team
4/7/2017
-
Perthera's Chief Bioinformatics Officer Speaking At American Medical Informatics Association (AMIA) 2017 Joint Summits Panels
3/28/2017
-
Perthera Adds Germline Testing To Its Precision Cancer Analysis (PCA) For Cancer Patients
3/24/2017
-
Perthera Launches New Website To Provide "A New Understanding Of Precision Medicine And Cancer"
3/9/2017
-
Admiral James A. "Sandy" Winnefeld, Jr., (USN, RET) Becomes A Senior Advisor To Perthera
2/28/2017
-
George Davis Joins Perthera Board Of Directors
2/16/2017
-
Perthera Announces Partnership With Hope For Stomach Cancer Advocacy Organization
2/14/2017
-
Perthera Enters A Collaboration With Major Pharmaceutical Company To Identify Cancer Patients For Clinical Trials
2/1/2017
-
Perthera Announces Partnership With Lung Cancer Alliance To Provide No-Cost-To-Patient Precision Medicine Services Across The U.S.
11/15/2016
-
Perthera Secures $8.7 Million Investment From Pilot Growth Equity To Expand Global Leadership In Precision Cancer Analysis ("PCA")
6/29/2016
-
Thomas Jefferson University Taps Perthera For Multi-Omic Molecular Diagnostic Analyses
9/24/2015
-
Personalized Cancer Solutions Innovator Perthera Named Finalist In Virginia Velocity Business Plan Competition
9/4/2015
-
Perthera To Host Breakfast Roundtable During ASCO Annual Meeting In Chicago
5/18/2015
-
Perthera Announces Andrew Mignatti As CEO
3/4/2015